Guangdong Hybribio Biotech Co (SZSE:300639) 5-Year EBITDA Growth Rate : 32.70% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Guangdong Hybribio Biotech Co 5-Year EBITDA Growth Rate?

Guangdong Hybribio Biotech Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥-0.05.

During the past 12 months, Guangdong Hybribio Biotech Co's average EBITDA Per Share Growth Rate was -105.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -22.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 32.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 29.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Guangdong Hybribio Biotech Co was 120.00% per year. The lowest was -22.40% per year. And the median was 39.40% per year.

Competitive Comparison of Guangdong Hybribio Biotech Co's 5-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Guangdong Hybribio Biotech Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guangdong Hybribio Biotech Co's 5-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guangdong Hybribio Biotech Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Guangdong Hybribio Biotech Co's 5-Year EBITDA Growth Rate falls into.

Guangdong Hybribio Biotech Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Guangdong Hybribio Biotech Co (SZSE:300639) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Guangdong Hybribio Biotech Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Guangdong Hybribio Biotech Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangdong Hybribio Biotech Co (SZSE:300639) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guangdong Hybribio Biotech Co Ltd (SZSE:300639) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

D 5-3-3-4, North High-tech Zone, Economic Development Zone, Chaozhou City, CHN, 521000

Website

http://www.hybribio.cn

Guangdong Hybribio Biotech Co Ltd is a Chinese company engaged in offering vitro diagnostic assays. Its products include in-vitro diagnostic kits, female sample collection kit, DNA extraction kit, and other devices. The company's products help in the infectious pathogens detection and genetic disease detection, including human papillomavirus, thalassemia, G6PD, hearing loss susceptibility, phenylketonuria, and early cancer detection, among others. The company has a business presence in China and various other countries.

Guangdong Hybribio Biotech Co (SZSE:300639) Headlines

No Headlines